Solana

Dogecoin (DOGE) fell sharply reaching a 24-hour low of $0.164 near press time on Thursday night. The cryptocurrency traded 31.04% lower at $0.21 at press time. Even as the meme cryptocurrency continues to slide, other coins such as Bitcoin Gold (BTG) and Solana (SOL) are on a run. See Also: How to...

Bitcoin (BTC) has sunk $7,066 from its Friday highs — about 11% over the weekend — and traded significantly below the $60,000 levels at press time late Sunday. Meanwhile, Dogecoin (DOGE) and several other cryptos are continuing to shoot up. What Happened: The apex...

Even though major cryptocurrencies like Bitcoin (BTC) and Ethereum (ETH) were in the red at press time, there are some coins that were bucking the trend. Is it now the time to buy Enjin Coin (ENJ), WazirX (WRX), Celsius (CEL), Ethereum Classic (ETC), or Solana (SOL)? ENJ: The coin of a company that...

Smart contract platforms have reached a combined market cap of $280 billion with an Ethereum (ETH) dominance of 57.92% at press time. Nevertheless, the so-called Ethereum killers are making rapid strides upwards and emerging as challengers to the second-largest cryptocurrency by market cap....

The rally in number one and number two cryptocurrencies by market capitalization — Bitcoin (BTC) and Ethereum (ETH) — may have toned down but there is still plenty of upwards action visible on the cryptocurrency markets. What Happened: BTC traded 7.96% lower at $52,250.75 and ETH...

Bitcoin (BTC) and Ethereum (ETH), the two top cryptocurrencies by market cap, remained muted on Wednesday night but many smart contract coins were rallying. What Happened: BTC price traded 3.47% lower at $44,829.47 and ETH was down 4.23% at $1,730 at press time. So-called Ethereum-killer coins...

An alternative to Ethereum (ETH) saw heightened interest on a day when cryptocurrency market capitalization eroded by 18.51%. What Happened: Solana (SOL) — a six-month-old cryptocurrency — founded by Anatoly Yakovenko and designed by a team of engineers from big tech companies such as...

Diagnostic healthcare products manufacturer Quidel Corporation (NASDAQ: QDEL)'s shares are not fully reflecting the company's growth potential and likely positive estimate revision bias, according to Raymond James.  The Analyst Raymond James analyst Nicholas Jansen upgraded shares...